Evaluation of biomarkers of acute kidney injury (AKI) in the ICU population.

Evaluation of biomarkers of acute kidney injury (AKI) in the ICU population. - Evaluation of biomarkers of acute kidney injury (AKI) in the ICU population.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000004503

Enrollment

200

Registered

2010-11-08

Start date

2010-11-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute kidney injury

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: An adult ICU population at the Okayama University Hospital entered by surgical operation, hemorrhage, infection, shock, respiratory failure, brain disorder, renal disorder, collagen disease, endocrinal disease, neural disorder, allergic disorder, blood disorder, metabolic disorder, trauma, burn injury, et. al.

Exclusion criteria

Exclusion criteria: The patients already performing renal replacement therapy by end-stage renal disease. The patients that informed consent was obtained. Minority (under 20 years old) The patients that was discharged ICU after entering ICU for 24 hours.

Design outcomes

Primary

Measure	Time frame
The relationship between the development of AKI and serum/ urinary biomarkers.	—

Secondary

Measure	Time frame
1)maximum RIFLE/AKIN class, 2) necessity of renal replacement therapy,3)renal function discharging the ICU, 4)ICU stay, 5)mortality, of AKI patients.	—

Countries

Japan

Contacts

Public ContactYohei Maeshima

Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences Department of Medicine and Clinical Science

086-235-7235

Outcome results